状胆瘤患者的五年生存率:单中心回顾性研究
相关实验视频
Updated: Jun 12, 2026

09:19
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
3.6K
HyeJeong Jeong1,2, Hee Joon Kim3, Soo Yeun Lim1,4
1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Annals of surgical treatment and research
|August 11, 2025
概括
状胆瘤的长期存活是具有挑战性的. 这项研究确定了N2阶段和瘤生物学作为影响切除后5年生存率的关键预后因素.
科学领域:
- 肝胆道手术 肝胆道手术
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 由于诊断迟到,状胆管癌的预后不好.
- 治疗切除对于这些患者的长期存活至关重要.
- 状胆管癌的手术后5年生存率显著在14%至48%之间.
研究的目的:
- 为了确定影响状胆管癌的长期生存的预后因素.
- 为了评估这种恶性瘤的治愈切除后的结果.
主要方法:
- 对449名患者进行回顾性分析,这些患者接受了状胆管癌的治疗意图切除.
- 收集的数据包括人口统计,手术/瘤结果,并发症,复发,病理和存活率.
- 考克斯的比例危险模型被用来分析预后因素.
主要成果:
- 中位数无病生存时间为19个月,中位数生存时间为40个月.
- 一年,3年和5年的生存率分别为82.8%,53.7%和35.8%.
- 整体5年生存率为35.8%.
结论:
- N2阶段和瘤生物学被确定为影响5年生存率的重要因素.
- 这些发现有助于预测结果,并指导状胆管癌的治疗策略.
相关概念视频
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

